Carolina Gomez Casas
Carolina Gomez Casas has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anita Shukla
School of Engineering, Brown University, Providence, RI, USA; Institute for Biology, Engineering, and Medicine, Brown University, Providence, RI, USA
2 shared publications - Emily S. Day
Department of Biomedical Engineering University of Delaware Newark Delaware USA
2 shared publications - Megan N. Dang
Department of Biomedical Engineering
2 shared publications - Carly Deusenbery
School of Engineering, Center for Biomedical Engineering, Brown University, Providence, Rhode Island 02912, United States
1 shared publication Craig Klevan
School of Engineering, Brown University, Providence, RI, United States
1 shared publication- George C. Kramarenko
Department of Biomedical Engineering
1 shared publication
Latest Publications
- Open Access
- 27 January 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (5) , 8836-8847
Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and accounts for up to 20% of all breast cancers. Since conventional chemotherapy and radiotherapy are ineffective against TNBC, nanoparticle-based medicines are being investigated as a potentially superior treatment option. Of such platforms, antibody–nanoparticle conjugates have been shown to precisely target diseased cells through selective antigen binding and to regulate oncogenic cellular signaling by blocking ligand activation of the targeted receptor. For example, silica core-gold shell “nanoshells” (NS) conjugated to Frizzled7 (FZD7) antibodies can preferentially bind TNBC cells to suppress Wnt signaling and inhibit disease progression. To improve understanding of antibody nanoconjugate structure/function relationships, in this study, we evaluated the influence of antibody loading density on the ability of FZD7-NS conjugates to bind TNBC cells, suppress Wnt signaling, and inhibit oncogenic cell behavior. We found that a lower antibody loading density of ∼60 antibodies per NS provided increased TNBC cellular binding and enhanced therapeutic efficacy compared to a higher antibody loading of ∼170 antibodies per NS. Specifically, the low-density FZD7-NS exhibited ∼2× greater binding avidity to MDA-MB-231 human TNBC cells than high-density FZD7-NS, yielding more robust inhibition of several Wnt target genes, as measured by RT-qPCR. Congruently, tumor spheroids formed from MDA-MB-231 cells that were pretreated with low-density FZD7-NS had significantly reduced area, metabolic activity, and cell number compared to those treated with high-density FZD7-NS. These results emphasize the importance of determining the appropriate surface ligand density when designing antibody–nanoparticle conjugates for therapeutic utility.
- 27 January 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (5) , 8836-8847
Open AccessLoading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and accounts for up to 20% of all breast cancers. Since conventional chemotherapy and radiotherapy are ineffective against TNBC, nanoparticle-based medicines are being investigated as a potentially superior treatment option. Of such platforms, antibody–nanoparticle conjugates have been shown to precisely target diseased cells through selective antigen binding and to regulate oncogenic cellular signaling by blocking ligand activation of the targeted receptor. For example, silica core-gold shell “nanoshells” (NS) conjugated to Frizzled7 (FZD7) antibodies can preferentially bind TNBC cells to suppress Wnt signaling and inhibit disease progression. To improve understanding of antibody nanoconjugate structure/function relationships, in this study, we evaluated the influence of antibody loading density on the ability of FZD7-NS conjugates to bind TNBC cells, suppress Wnt signaling, and inhibit oncogenic cell behavior. We found that a lower antibody loading density of ∼60 antibodies per NS provided increased TNBC cellular binding and enhanced therapeutic efficacy compared to a higher antibody loading of ∼170 antibodies per NS. Specifically, the low-density FZD7-NS exhibited ∼2× greater binding avidity to MDA-MB-231 human TNBC cells than high-density FZD7-NS, yielding more robust inhibition of several Wnt target genes, as measured by RT-qPCR. Congruently, tumor spheroids formed from MDA-MB-231 cells that were pretreated with low-density FZD7-NS had significantly reduced area, metabolic activity, and cell number compared to those treated with high-density FZD7-NS. These results emphasize the importance of determining the appropriate surface ligand density when designing antibody–nanoparticle conjugates for therapeutic utility.
- Open Access
- 2 January 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 502, 141023
Shea-derived cationic surfactants are effective and low-toxicity alternative co-surfactants for foam fractionation of per- and polyfluoroalkyl substances (PFAS)
- 2 January 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 502, 141023
Open AccessShea-derived cationic surfactants are effective and low-toxicity alternative co-surfactants for foam fractionation of per- and polyfluoroalkyl substances (PFAS)
- 29 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 5 (9) , 7400-7410
pH-Responsive Swelling Micelles for the Treatment of Methicillin-Resistant Staphylococcus aureus Biofilms
- 29 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 5 (9) , 7400-7410
pH-Responsive Swelling Micelles for the Treatment of Methicillin-Resistant Staphylococcus aureus Biofilms
- 11 December 2020
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (1) , 68-76
Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells
Triple-negative breast cancer (TNBC) is an aggressive disease that requires new interventions. A promising approach to improve patient prognosis is to introduce tumor suppressive miR-34a into TNBC cells. Unfortunately, naked miR-34a is not effective therapeutically because it is degraded by nucleases and cannot passively enter cells. Nanocarriers designed to increase miR-34a stability and cellular entry have lacked specificity and potency. To overcome these limitations, we conjugated miR-34a to photoresponsive gold nanoshells (NS), which can release tethered miR-34a upon excitation with continuous wave (CW) or nanosecond (ns) pulsed near-infrared light to facilitate on-demand gene regulation. We demonstrate that miR-34a/NS can regulate downstream miR-34a targets following irradiation to reduce TNBC cell viability, proliferation, and migration. Further, we show ns pulsed light releases miRNA more effectively than CW light, and that released miR-34a is as potent as transfected miR-34a. These findings signify miR-34a/NS as promising tools for precisely controlled gene regulation of TNBC.
- 11 December 2020
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (1) , 68-76
Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells
Triple-negative breast cancer (TNBC) is an aggressive disease that requires new interventions. A promising approach to improve patient prognosis is to introduce tumor suppressive miR-34a into TNBC cells. Unfortunately, naked miR-34a is not effective therapeutically because it is degraded by nucleases and cannot passively enter cells. Nanocarriers designed to increase miR-34a stability and cellular entry have lacked specificity and potency. To overcome these limitations, we conjugated miR-34a to photoresponsive gold nanoshells (NS), which can release tethered miR-34a upon excitation with continuous wave (CW) or nanosecond (ns) pulsed near-infrared light to facilitate on-demand gene regulation. We demonstrate that miR-34a/NS can regulate downstream miR-34a targets following irradiation to reduce TNBC cell viability, proliferation, and migration. Further, we show ns pulsed light releases miRNA more effectively than CW light, and that released miR-34a is as potent as transfected miR-34a. These findings signify miR-34a/NS as promising tools for precisely controlled gene regulation of TNBC.